🇺🇸 FDA
Pipeline program

Venclyxto 100 mg film-coated tablets, Azacitidine Kabi 25 mg/mL powder for suspension for injection

IPC 2024-001

Phase 2 small_molecule active

Quick answer

Venclyxto 100 mg film-coated tablets, Azacitidine Kabi 25 mg/mL powder for suspension for injection for acute myeloid leukemia is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
acute myeloid leukemia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials